sj-pdf-6-tar-10.1177_17534666211034329 – Supplemental material for Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial

Rabe, Klaus F.; Martinez, Fernando J.; Singh, Dave; Trivedi, Roopa; Jenkins, Martin; Darken, Patrick; Aurivillius, Magnus; Dorinsky, Paul

doi:10.25384/SAGE.16450559.v1

sj-pdf-6-tar-10.1177_17534666211034329.pdf (127.84 kB)

sj-pdf-6-tar-10.1177_17534666211034329 – Supplemental material for Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial

journal contribution

posted on 2021-08-26, 12:07 authored by Klaus F. Rabe, Fernando J. Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius, Paul Dorinsky

Supplemental material, sj-pdf-6-tar-10.1177_17534666211034329 for Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial by Klaus F. Rabe, Fernando J. Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius and Paul Dorinsky in Therapeutic Advances in Respiratory Disease